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Sllmmary 
B lymphocyte precursor cells in mouse bone marrow develop in close association with stromal 
cells which provide essential growth signals. To identify molecules that may normally play a 
role in this interaction we have examined the in vivo binding of a new monoclonal antibody 
(mAb) (KMI6) that recognizes a determinant on a bone marrow stromal cell line (BMS2) in 
vitro. Flow cytometric and radioautographic evaluations  revealed that the antigen recognized 
by KMI6 is represented on the surface of an extremely small number of cells in bone marrow 
cell suspensions from adult mice. An apparent molecular mass of 110 kD was obtained by surface 
labeling of a stromal cell done and immunoprecipitation. Purified mAb KMI6 labeled with lasI 
was then given intravenously to young C3H/HeJ mice. Unbound mAb was washed out by cardiac 
perfusion and femoral bone marrow was examined by light and dectron microscope radioautography. 
KMI6 labeling was heavy on the plasma membrane of many stromal cells, especially those located 
towards the outer subosteal region. The KMI6-1abeled stromal cells were usually associated with 
cells of lymphoid morphology  which they often completely surrounded. The labeling was restricted 
to areas of stromal cell plasma membranes in contact with lymphoid cells. The lymphoid cells 
themselves,  as well as macrophages and other hemopoietic cells, failed to bind mAb KMI6 
significantly.  Stromal cells in bone marrow depleted of hemopoietic cells by "y-irradiation (9,5 
Gy) bound mAb KMI6 at reduced intensity. The results demonstrate that the KMI6 determinant, 
a 110-kD protein, is expressed on bone marrow stromal cells in vivo. Its restriction to areas of 
interaction with lymphoid ceils suggests a role in forming microenvironmental niches  of B 
lymphopoiesis. The surface membrane of individual stromal cells may thus be functionally polarized 
towards interacting B cell precursors  and other hemopoietic cells. 
B  cells are continuously generated in the bone marrow 
under the influence of local microenvironmental con- 
trols (1, 2). Both in long-term bone marrow cultures and 
in vivo, precursor B lymphocytes develop in close association 
with certain stromal cells (2-4). Actual adhesion to the stromal 
cells and access to stromal cell products are needed for early 
steps in B lymphocyte differentiation and proliferation (2, 
5-8). Clones of individual stromal cells capable of supporting 
B cell development have been defined (5-14).  Stromal cells 
and their products are equally important, however, in sup- 
porting other hemopoietic lineages (15). The molecular in- 
teractions between individual stromal cells and associated 
precursor cells in vivo are thus central to the functional orga- 
nization of stromal cells and their role in regulating B lym- 
phopoiesis and other aspects of hemopoiesis. 
Adhesion molecules so far shown to play a role in B lym- 
phopoiesis in vitro include CD44, hyaluronate, very late an- 
tigen  41  (VLA-4)  and  vascular  cell  adhesion molecule 1 
(VCAM-1)  (16-19).  These products appear to be function- 
ally important because antibodies to the individual molecules 
can prevent lymphopoiesis when added to bone marrow cul- 
tures (16, 19). The effects are not restricted to B cell genesis, 
however, as myelopoiesis is also being impaired when the an- 
tibodies are added to appropriate cultures (16, 19). 
A new mAb (mAb KMI6) has now been raised against 
a B cell-supportive stromal cell done, BMS2, as a potential 
marker of B lineage interaction. The mAb was selected for 
its strong binding to BMS2 stromal cells, and lack of hema- 
topoietic cell labeling. It has yet to be shown, however, that 
1 Abbreviations used in this paper: EM,  electron microscopy; LM, light 
microscopy; VCAM,  vascular  cell adhesion molecule; VLA, very late 
antigen. 
927  j. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/92/10/0927/09 $2.00 
Volume  176  October 1992  927-935 the KMI6 cell surface determinant is constitutively expressed 
in vivo.  Some other surface molecules on stromal cells are 
expressed  only under culture conditions (2). 
The present work has been designed to determine the ex- 
pression of the KMI6 determinant and its precise  location 
at the stromal-precursor cell interface under normal circum- 
stances in vivo. Radiolabeled purified mAb KMI6 has been 
administered intravenously to mice, and its binding sites in 
the bone marrow visualized by electron microscopy and high 
resolution radioantography (3, 4). The findings reveal a con- 
stitutive, in vivo expression  of KMI6 determinant, appar- 
ently restricted to certain areas of stromal cell surface mem- 
branes at the interface with undifferentiated lymphoid cells. 
Materials and Methods 
Antibody Isolation and Immunoprecipitation of  Determinants Recog- 
nized by mAb KMI6.  The BMS2 stromal cell clone was established 
from the bone marrow of (C57BL/6  x  DBA/2)FI mice and has 
been extensively  characterized (12, 15). These cells  were used repeat- 
edly to immunize LOU/MN rats before fusion of their sph.'en  cells 
with the murine Sp2/0 hybridoma. Drug-resistant hybrids were 
selected  for antibody production by an ELISA  assay  with fixed  BMS2 
cells. Positive wells were additionally tested for reactivity with 
hemopoietic cells by flow cytometry. Antibody produced by the 
cloned KMI6 hybridoma stained the BMS2 ceils, but not suspen- 
sions prepared from spleen, thymus, lymph nodes, or bone marrow. 
Ascites was then prepared in immunodeficient SCID mice  and the 
antibody purified  by ABx column chromatography  (J.T. Baker; Phil- 
lipsburg, NJ). 
BMS2 cells were surface labeled with N-hydroxy-sulfosuccini- 
midobiotin (Pierce Chemical Co., Rockford, IL) before extraction 
with NP-40 (Sigma Chemical Co., St. Louis, MO) exactly as de- 
scribed (19). The labeled material was then precleared by repeated 
incubation with sepharose  beads coated with goat anti-rat IgG an- 
tibodies. Immunoprecipitations were then performed with similar 
beads loaded with either normal rat IgG, or purified KMI6 anti- 
body. Recovered protein was eluted by boiling in sample buffer 
and run on 10% SDS-PAGE. After transfer to Immobilon P mem- 
branes (Millipore Corp., Bedford, MA) immunoprecipitates were 
revealed by treatment with an avidin-horseradish peroxidase con- 
jugate,  followed by 4-chloro-l-napthol  and  hydrogen peroxide 
(Sigma Chemical Co.). 
Mice.  Male  C3H/HeJ mice, 3-4-wbold, were purchased from 
the Jackson Laboratory (Bar Harbor, ME). All mice were housed 
in sterile microisolator  cages (Laboratory  Products Inc., Maywood, 
NJ). Food and water were provided ad libitum. 
Irradiation.  Mice were placed in  a  Gamma-Cell  irradiator 
(t~ZCs) chamber and received a single dose of 9.5 Gy 3,-irradiation 
(1.37 Gy/min). 
Radioiodination of  A.~nity-tmnfied Rat IgG.  mAb KMI6 (rat IgG 
2a) was used at a concentration of 2.5 mg/ml. To radiolabel tyro- 
sine residues, 150/~g aliquots of mAb were couphd to carrier-free 
Nal2SI (1.5 mCi; sp act 1.5  x  107/~ci//xg)  by a modified chlora- 
mine-T method. The final concentration of mAb was ~50/~g/ml 
in PBS (pH 7.2). 
Bone Marrow Cell Sampling and In  Vitro Binding of 12SI-mAb 
KMI6.  Mice  were killed by cervical dislocation and femurs were 
removed. Bone marrow cell suspensions were prepared by flushing 
the femoral shafts with 10% FCS in Eagle's MEM (Gibco Labora- 
tories, Grand Island, NY).  Bone marrow cell suspensions were 
counted with an electronic particle counter (Coulter Electronics, 
Hiahah, FL) and the cellularity adjusted to 40  x  1@ cells/ml be- 
fore 100 #1 aliquots were incubated with 100 #1 of 12SI-KMI6 for 
30 min on ice. The cells were then centrifuged through 6% BSA 
in PBS at 1,100 rpm for 8 rain. The supematant was aspirated and 
the pellet washed four times by centrifugation in PBS (pH 7.4). 
Cell pellets were suspended in 6% BSA/PBS and smeared onto 
gelatin-coated glass slides, fixed in absolute methanol, and dipped 
in Kodak d52 radioautographic  emulsion (Kodak  Canada, Toronto, 
ON) (3, 4). 
In Vivo Immunolabeling with Radioiodinated mAb KMI6.  Groups 
of six control and six irradiated mice were anaesthetized  with 1.6% 
chloral hydrate in sterile saline  intraperitoneally (0.25 ml/gm body 
weight). The external  jugular vein was exposed and 100 #1 of 12sI- 
mAb was injected directly into the blood stream. 3 min later, the 
blood was cleared from the circulation by whole-body cardiac per- 
fusion. A syringe pump (model 355; Sage Instruments, White 
Plains, NY) was used to deliver (3 ml/min) cold Ringer's solution 
to wash out unbound antibody and blood followed  by a cacodylate- 
buffered solution of 2.5% glutaraldehyde and 2.0% acrolein (pH 
7.2) to fix the tissues in situ. 
Tissue Processing and Radioautography.  Femoral  shafts of per- 
fusion-fixed mice were removed and placed in fixative at 4~  for 
12 h before decalcification  in EDTA (10% wt/vol, pH 7.2) at 4~ 
for 5-7 d. Decalcified  femurs were postfixed in potassium ferro- 
cyanide-reduced  osmium tetmxide, dehydrated  in acetone, infiltrated 
and embedded in Epon 812 (J.B.EM, St. Laurent, QC) as described 
(3, 4). Mid-diaphyseal  transverse sections of  bone marrow were cut 
for light microscopy  (LM) and electron microscopy  (EM). LM sec- 
tions were stained with iron hematoxylin and iron alum before they 
were dipped in Kodak NTB2 emulsion (Kodak Canada, Toronto, 
ON) and exposed for 1-4 wk. EM sections were placed on celloidin- 
treated glass slides, coated with a monolayer of Ilford L4 emulsion 
(Ilford, Essex, UK), and exposed for 8-24 wk. Sections  were stained 
in aqueous uranyl acetate and lead citrate. Specimens were scanned 
and photographed on an electron microscope (model 400; Philips, 
Eindhoven, the Netherlands). 
Morphometric Analysis of  mAb KMI6 Binding in Bone Marrow Sec- 
tions.  Photomicrographs of labeled stromal ceU processes were 
traced at a constant magnification of 14,500 and the information 
was stored using the MOP-Videoplan  image analysis  program (Carl 
Zeiss of Canada Ltd., Don Mills, ON). The perimeters of lym- 
phoid cells associated  with labeled  stromal  cell processes were traced, 
and measurements of their maximum diameters at x- and y- axes 
were derived. The MOP Videoplan was also used to measure the 
distance between the center of individual radioantographic grains 
and hemopoietic cell plasma membranes. 
Analysis of mAb KMI6 Labeling in Mouse Bone Marrow Suspen- 
sions.  Subsequent  to in vitro exposure to 12SI-mAb, three bone 
marrow smears from each mouse were analyzed after 1, 7, and 21 d 
of radioantographic  exposure. By standard hematologic  criteria, cells 
were categorized as lymphoid, erythroid, granulocytic, or other, 
and the number of radioantographic grains associated with each 
cell was counted. 
Results 
mAb  KMI6,  a  new antibody raised  against the BMS2 
stromal cell clone, bound strongly to the cultured stromal 
cells, but by flow cytometry was found to label an extremely 
small number of cells in suspensions  of bone marrow from 
adult mice. Radioantographic evaluation of  bone marrow cells 
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tects an  ,,o110-kD protein on 
BMS2 stromal  cells. Biotin-hbeled 
cells  were  extracted  and immuno- 
precipitated  with normal  rat IgG 
(A) or KMI6 antibody  (B). The 
positions of size standards  are in- 
dicated. 
from young mice exposed to 12SI-mAb KMI6 also showed 
only near-threshold labeling  of a  few bone  marrow cells 
(1.8-2.5%), mainly of lymphoid morphology. Immunopre- 
cipitation and PAGE of the new stromal cell determinant 
defined by mAb KMI6 resolved a single band with an ap- 
parent molecular mass of ~110-kD  (Fig.  1). The mobility 
of the immunoprecipitated species was identical under reducing 
and nonreducing conditions (not  shown). 
mAb KMI6 Binding to Bone Marrow Stromal Cells In Viva 
After administering lzSI-mAb KMI6 intravenously to young 
mice, well-marked binding of the mAb was detected in sec- 
tions of femoral bone marrow. Radioautographic grains, in- 
dicative of KMI6 binding,  were revealed by LM,  forming 
linear arrangements between and around the hemopoietic cells 
(Fig.  2 a).  This labeling was particularly evident in outer 
regions of the bone marrow towards the surrounding bone. 
Low power EM demonstrated the presence of high intensi- 
ties of KMI6 labeling localized to certain extravascular cel- 
lular dements, background grains being rarely seen (Fig.  2 
b). Endothelial cells and components of the walls of venous 
sinusoids  and  arterioles  were  devoid  of  KMI6  labeling 
(Fig.  2  b). 
KMI6 binding often appeared to be located around the 
perimeter of hemopoietic cells which exhibited an undifferen- 
tiated lymphoid morphology (Fig.  2).  High magnification 
revealed, however, that  these lymphoid ceils were actually 
surrounded by thin cytoplasmic extensions from stromal re- 
ticular cells (Fig.  3, a-d).  There was intimate contact, but 
no specialized  junctions, between the adjacent cell membranes. 
The majority of the radioautographic grains were localized 
over the stromal cell processes,  suggesting that these, rather 
than the lymphoid call plasma membrane, were the sites of 
KMI6 binding (Fig.  3,  a  and b). 
Sheets of cytoplasm of mAb KMI6-1abeled stromal cells, 
up to 1 #m in width, often completely encircled the associated 
lymphoid cell,  and could be followed three-dimensionally 
around the cell in serial sections (Fig. 3, a-d). The lymphoid 
cell thus appeared to be virtually enclosed within a cup-like 
Filcarr  2.  Light  and dectron microscope  radioantography  of mAb KMI6 binding in mouse  femoral  bone marrow. (a) Two hemopoietic  cells (arro~ 
/~ads) surrounded  by radioantographic  grains revealing  binding of l~I-mAb KMI6 in an area adjacent to the surrounding  cortical  bone (radioauto- 
graphic exposure  7 d,  x3600). (b) Radioautographic  grains associated  with the plasma membranes  of stromal reticular  cell  processes  surrounding  two 
hemopoietic cells (the underlying  sinus endothelium  does not bind the antibody). Exposure 10 wk,  ￿ 
929  Jacobsen  et al. Figure 3.  Two serial sections of a single lymphoid  cell (a and b) (from Fig. 1 B) and accompanying drawings (c and d) illustrating  extensive association 
with a stromal cell. Processes from the stromal cell surround the lymphoid cell in two planes of the section and express the KMI6 determinant on 
surfaces of contact between the two cells. Exposure  10 wk,  x 7700. 
extension of the stromal cell cytoplasm. Whereas this exten- 
sion exhibited KMI6 binding, other processes of the same 
stromal cell, not enveloping the lymphoid  cell, remained com- 
pletely unlabeled by mAb KMI6 (Fig. 3, a-d). In some planes 
of section, stromal cell processes  extended only partially around 
a lymphoid cell.  In such cases, the KMI6 determinant was 
localized strictly to the area of plasma membrane contact be- 
tween the two cells (Fig.  4).  Other regions of the plasma 
membrane of  both cells showed no mAb KMI6 binding. The 
expression of the KMI6 determinant thus appeared to be re- 
stricted to the stromal-lymphoid call interface. 
The intensity of KMI6 expression by various stromal cells 
within the same bone marrow sample varied widely, as re- 
vealed  by the density of radioautographic grains per unit length 
of stromal cell profile (Fig. 5). Not all stromal cell processes 
associated with undifferentiated lymphoid cells were labded 
by mAb KMI6  (data  not shown). 
The morphology of KMI6-expressing stromal cells and as- 
sodated lymphoid cells is illustrated in Figs. 3-5. The stromal 
cell cytoplasm was electronlucent and contained a few profiles 
of rough endoplasmic reticulum, small vesicles and occasional 
mitochondria, but was devoid of lysosomes or phagosomes. 
Electron-dense granules resembling fat droplets were some- 
times seen. The stromal cell nucleus, revealed occasionally 
in the plane of section, had prominent nucleoli and a moder- 
ately dispersed chromatin pattern. The associated lymphoid 
cells were large cells, having a mean diameter of '~7.5 gm, 
as measured in sections using the MOP-Videoplan and cor- 
recting for the random planes of section. The cytoplasm was 
relatively plentiful, the mean ratio of cytoplasmic to nuclear 
area in sections being 1.0:1.4. The cytoplasm contained 2-9 
mitochondria per cell profile,  a few cisternae  of rough en- 
doplasmic reticulum, many free ribosomes, a small Golgi com- 
plex of 3-4 saccules, and some electron-dense vesicles. The 
930  Restricted  Expression of a Stromal Cell Determinant in Mouse Bone Marrow Figure 4.  A stromal cell (S) sectioned  through its nucleus, sends cytoplasmic  processes  around an undifferentiated  lymphoid  cell (see &awing). 
Radioautographic  grains,  indicating  KMI6 binding,  are restricted  to regions  where  stromal  cell  processes  contact  the lymphoid  cell.  Exposure  10 wk, x 8,800. 
lymphoid cell nucleus had a relatively dispersed euchromatin 
pattern with patchy heterochromatin around the nuclear enve- 
lope and prominent nucleoli. There appeared to be no con- 
sistent morphological differences between lymphoid cells as- 
sociated with stromal cell processes  of high and low KMI6 
expression, respectively. Some cells associated with KMI6- 
bearing stromal cells were in mitosis (data not shown). Oc- 
casionally, small groups of  lymphoid cells were encompassed 
in a network of KMI6 + stromal cell processes. 
Resident macrophages in the bone marrow, whose com- 
plex cytoplasmic processes extended through the parenchyma, 
did not bind KMI6. These cells were clearly distinguishable 
from the stromal reticular cells by their abundance of phago- 
somes and other inclusion bodies, characteristic lysosomal net- 
work and voluminous cytoplasm. 
No cells other than those of  undifferentiated  lymphoid mor- 
phology appeared to be associated with sites of KMI6 ex- 
pression orr stromal cells. Nonlymphoid cells, notably granulo- 
cytic cells, were often in contact with KMI6-binding stromal 
cells, but were not adjacent to the region of KMI6 labeling. 
Measurements of the distance between radioautographic grains 
and  the nearest  plasma  membrane of lymphoid cells  and 
granulocytic (myeloid) cells revealed that the KMI6 epitope 
was expressed highly on stromal elements immediately adja- 
cent to lymphoid cells. Over 75 %  of all the grains were lo- 
cated within a distance of 0.2/~m from their center to the 
plasma membrane of a lymphoid cell (Fig. 6). Most granulo- 
cytes were further removed from KMI6 binding  sites. 
Effect of  ~/-Irradiation on mA b KMI6 Binding to Bone  Marrow 
Stromal Cells In Viva  The bone marrow 2 d  after 9.5 Gy 
whole-body 3,-irradiation was largely devoid of hemopoietic 
cells, but stromal reticular cells and their processes were prom- 
inent and more clearly delineated than in normal bone marrow 
(Fig.  7). The parenchyma, reduced to hypocellular columns 
between widely dilated sinusoids,  contained stromal retic- 
ular cell bodies and cytoplasmic processes  that formed con- 
centric layers in the outer subosteal region (Fig.  7 b). Other 
cells in the parenchyma included adipocytes, which were often 
adjacent to sinusoids and were more abundant than usual, 
blast-like cells, megakaryocytes, erythrocytes, and small clusters 
of granulocytes. 
mAb KMI6 binding was distinctly evident on the stromal 
cell processes throughout the irradiated bone marrow, in both 
outer and central areas (Fig. 7). Most radioautographic grains 
were localized directly over stromal cell profiles.  Compared 
with nonirradiated bone marrow, the labeling was reduced 
in intensity and was not localized in patches. Sites of mAb 
KMI6 binding, were distributed at intervals evenly along the 
length of some, but not all, stromal cell processes (Fig.  7 b). 
3,-irradiated bone marrow also showed mAb KMI6 labeling 
of the endothelium of venous sinusoids in low intensities, 
the media of arterioles external to  the elastic  lamina (Fig. 
7 a) and,  occasionally, canaliculi of some megakaryocytes. 
ExtramTeloid Binding of mAb KMI6.  In addition to bone 
marrow stromal reticular cells,  125I-mAb KMI6 bound  to 
stromal cells in the red pulp of the spleen, most evidently 
931  Jacobsen  et al. Figure  5.  The density of  the KMI6 determinant  expression on stromat 
cells varies considerably. (a) A lymphoid cell with an undulating nuclear 
profile surrounded by stromal cell processes that show a low level of mAb 
KMI6 binding. (b) A lymphoid cell surrounded by a heavily labeled stromal 
cell. Exposure  10 wk,  x8,250. 
Figure  7.  Binding ofmAb KMI6 to radioresistant bone marrow stromal 
cells 2 d after whole-body ~-irradiation  (9.5 Gy). (a) Central area of bone 
marrow showing sectioned stromal cell processes with overlying radioau- 
tographic grains (arrows). Arterioles (A) and endothelial cells (arrowheads) 
also show mAb KMI6 labeling (x 3,500). (b) Peripheral area of  bone marrow 
containing  layers of stromal cell processes, showing low levels of KMI6 
labeling  (circles). Exposure  10 wk,  x11,000. 
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Figure  6.  Distance between radioautographic grains and plasma mem- 
branes of lymphoid or myeloid cells. 
after irradiation, and to microvilli on the sinusoidal surface 
of hepatocytes. Immunoperoxidase KMI6 staining of cryosec- 
tions revealed KMI6 binding to a variety of tissue elements, 
including endothelial cells in the heart, kidney glomerular 
capsule, hair follides and epidermis, reticular elements in ex- 
trafollicular regions of lymph nodes and thymus, and bone 
marrow megakayrocytes (data not shown). In 14-d fetal liver, 
erythroid cells, accounting for approximately one half of the 
total nucleated cells, showed KMI6 cell surface binding as 
detected by fluorescence labeling,  flow cytometry, and cell 
sorting (data not shown). 
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The present study demonstrates that a cell surface mole- 
cule expressed by a lymphocyte-supporting  stromal cell done 
in vitro is expressed by certain stromal reticular cells in the 
bone marrow under normal circumstances in vivo. The pro- 
tein determinant recognized by mAb KMI6 appears to be 
the first example of a molecule whose expression on stromal 
cell processes is limited to restricted areas of the surface mem- 
brane, interfacing with cells of undifferentiated lymphoid mor- 
phology. The findings suggest that stromal cells and some 
of their products are polarized towards individual interacting 
hemopoietic cells in vivo, providing a possible basis for the 
multilineage function of bone marrow stromal cells. 
The KMI6 cell surface protein is expressed only by stromal 
reticular cells in the bone marrow, not by hemopoietic cells. 
In vivo administration of radiolabeled mAb KMI6 gives radio- 
autographic labeling localized to stromal cell processes both 
in normal bone marrow, when stromal cells are closely as- 
sociated with hemopoietic cells, and after lethal 7-irradiation, 
when hemopoietic cells are virtually absent. Single cell sus- 
pensions of bone marrow, from which stromal cells have been 
eliminated by disruption,  show virtually no mAb KMI6 
binding by either flow cytometry or radioautography. The 
low level of radioautographic mAb KMI6 labeling shown 
by some lymphoid cells in vitro could represent the presence 
of fragments of adherent stromal cell membrane remaining 
after the breakdown of stromal cell-lymphoid cell associa- 
tions. Not all reticular cells in the bone marrow express the 
KMI6 determinant, however, suggesting that this property 
defines a particular subset of stromal reticular cells. 
Comparable heterogeneity is evident among cultured bone 
marrow stromal cells. Cloned stromal cell lines exhibit a va- 
riety ofphenotypic and functional properties (2, 5-12). With 
respect to B cell genesis,  some stromal cell clones  support 
the development of the earliest progenitor B cells, others can 
sustain the proliferation of more differentiated I1-7-respon- 
sive pro-B and pre-B cells, whereas some are devoid of lym- 
phocyte supporting activity (5, 10-14).  In contrast with re- 
ticular cells, the resident macrophages of the bone marrow 
stroma, which do not bind lymphoid  progenitor cells in long- 
term bone marrow culture (20), are entirely lacking in KMI6 
surface protein in vivo. 
KMI6 expression demarcates areas of intimate association 
between stromal cell processes and individual lymphoid pro- 
genitor cells. As seen by EM, depending upon the plane of 
section, this association takes the form of either a thin ring 
of KMI6-bearing stromal cell cytoplasm completely encir- 
cling the lymphoid cell (Figs. 2, 3, and 5) or extensions from 
the body of the stromal cell partially embracing the lymphoid 
cell (Fig.  4). These appearances  suggest that three-dimen- 
sionally, the lymphoid cell is located within a deep goblet- 
like stromal cell extension whose inner surface displays KMI6 
protein. Small dusters of lymphoid cells have been observed 
to be associated with a single stromal cell. In addition, how- 
ever, nonlymphoid  cells, notably granulocytic precursors, may 
be associated with other indentations of the stromal cell sur- 
face not expressing KMI6. This interpretation, shown sche- 
matically in Fig. 8, suggests the formation of microenviron- 
mental "niches" for lymphoid cell development limited to 
restricted portions of the surface of stromal cells whose ac- 
tivities are directed specifically  towards the membrane interface. 
The concept of such a polarization of stromal cells, directing 
KMI6 protein expression towards lymphoid cells, finds parallels 
in associations between immune cells. In interacting with 
B lymphocytes to promote Ig synthesis,  T  helper lympho- 
cytes show a polarization of cytoskeletal  elements and cell 
organelles, as well as a vectorial direction of cytokine secre- 
tion towards the interface with the B cell (21). CTLs become 
polarized towards target cells before lysing them (22). The 
present findings suggest a mechanism whereby individual 
hemopoietic lineages can be selectively regulated by soluble 
factors in the bone marrow, despite the close packing of di- 
verse  hemopoietic cells  in  the  extravascular  parenchyma. 
Stromal cell  factors  released  in  small amounts at  KMI6- 
expressing interfaces could stimulate the associated lymphoid 
cells without influencing nearby cells. In this way, more than 
one cell lineage could be independently regulated on the sur- 
face of an individual stromal cell. 
Interlineage competition in the bone marrow has been a 
long-recognized phenomenon, but its cellular basis has been 
unclear.  A reciprocal relationship between lymphocytopoi- 
esis and granulocytopoiesis has been repeatedly observed in 
perturbations of steady state conditions (23-25). Individual 
stromal cells are multifunctional with respect to cytokine in- 
teractions.  They can produce both CSFs and II.-7 and they 
display receptors for many cytokines (2, 14). Stimulation of 
pre-B cell proliferation by administered II-7, however, is as- 
sociated with decreased granulocytopoiesis (26) whereas, con- 
versely,  the  stimulation of neutrophil production by ad- 
ministered G-CSF diminishes B lymphocytopoiesis (27, 28). 
These effects have been conjectured to reflect a competition 
for a common pool of stem cells, but it now seems more 
probable that the underlying mechanism involves a competi- 
tion for stromal cell-related factors. The rapid proliferation 
of a stromal cell-associated precursor cell of a given lineage 
may induce an increased polarization and expansion of the 
respective lineage-directed area of stromal cell membrane at 
the expense of other associated lineages. The variation in in- 
tensity of expression of the KMI6 protein from one lymphoid 
..IB- KMI-6 
Figure  8.  Schematic  representa- 
tion of the proposed  localisation  of 
KMI6  determinant  at  the interface 
between  a  bone  marrow  reticular 
stromal cell and a lymphoid progen- 
itor cell (L). 
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tion state of the associated lymphoid cell and its capacity to 
induce stromal cell activities. In the absence of lymphoid cells 
in irradiated bone marrow, the expression of KMI6 protein 
by bone marrow stromal cells becomes diffuse and of low 
intensity. This seems unlikely to be the result of radiation- 
induced injury to the stromal cells because the expression of 
another surface molecule, VCAM-1, actually increases after 
identical irradiation treatment (Jacobsen K. and D.G. Osmond, 
unpublished data). Rather, the findings suggest that interac- 
tion with lymphoid progenitor cells may normally be in- 
strumental in inducing the patchy expression of KMI6 pro- 
tein in high intensities on polarized stromal cells. The ability 
of lymphoid interactions to influence stromal cell activities 
has been documented. A stromal cell done, ST2, which does 
not constitutively produce Ib7, can be induced to transcribe 
RNA for II,-7 when cocuhured with the II~7-dependent B 
cell line, DW34  (29). 
Further studies are indicated to identify positively the nature 
of the KMI6-associated lymphoid cells. These cells exhibit 
remarkably consistent appearances within the heterogeneous 
cell populations of the bone marrow. Their undifferentiated 
morphology would be generally consistent with that of primi- 
tive hemopoietic precursors, including muhipotential stem 
cells (30). Their size and cytoplasmic volume appear in most 
cases to be larger than those of hemopoietic stem cells (30), 
however, and they would appear greatly to exceed the stem 
cell population in frequency (30-33). On the other hand, their 
morphology is entirely consistent with that of early B220 + 
precursor B cells, such as those identified in SCID mice (34). 
The region of the bone marrow in which KMI6 labeling is 
most evident, tending towards peripheral areas near the sur- 
rounding bone, is one in which early precursor B cells are 
concentrated (3, 4, 34, 35). Double marker studies combining 
KMI6 with B220 and # chains will test the hypothesis sug- 
gested by the present work that the KMI6-associated lym- 
phoid cells are mainly precursor cells of the B lymphocyte 
lineage. 
Studies of the molecular nature of the 110-kD  KMI6 an- 
tigen, as well as its functional significance are underway. The 
addition of mAb KMI6 to long-term cultures of B lympho- 
cyte precursor cells on BMS2 stromal cells has had no effect 
on B cell genesis (19). This is not surprising since the KMI6 
antibody was not selected on the basis of a functional assay. 
However, the molecule recognized by KMI6 antibody is an 
interesting candidate for a number of possible functions. Firstly, 
it could be a transmembrane growth or differentiation factor. 
A number of recently characterized cytokines, such as stem 
cell factor (MGF, kit ligand) have a membrane orientation. 
The  KMI6  antigen  is  constitutively expressed on cloned 
stromal cell lines and is detectable as a cytoplasmic protein 
in sections of a variety of tissues. 
Although human CD34 is of similar size, preliminary ex- 
periments suggest that the KMI6 antibody does not recog- 
nize the human homologue.  Another candidate is  CD10 
(CALLA) and experiments are underway to see if KMI6 recog- 
nizes an endopeptidase like molecule. Still other possibilities 
are that it is a cell adhesion molecule of unknown function. 
If that is the case, the antibody is either directed to a func- 
tionally unimportant domain or has not been tested in an 
appropriate adhesion system. Molecular cloning would clarify 
these issues. Aside from demonstrating that stromal cells can 
be polarized to provide physical niches for interaction with 
hemopoietic progenitors, the present findings will stimulate 
structural studies of the KMI6 molecule. 
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